| Bioactivity | NMS-P945 is an ADC linker that can be used in the synthesis of antibody-drug conjugates (ADCs). NMS-P945 is suitable for conjugation to mAbs with reproducible Drug Antibody Ratio (DAR) >3.5[1]. |
| Name | NMS-P945 |
| CAS | 1466546-35-9 |
| Formula | C61H76ClN11O12S |
| Molar Mass | 1222.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Valsasina B, Novel thienoduocarmycin-trastuzumab ADC demonstrates Strong Anti-tumor Efficacy with Favorable Safety Profile in Preclinical Studies. Mol Cancer Ther. 2023 Sep 19. |
NMS-P945
CAS: 1466546-35-9 F: C61H76ClN11O12S W: 1222.84
NMS-P945 is an ADC linker that can be used in the synthesis of antibody-drug conjugates (ADCs). NMS-P945 is suitable for
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.